Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
43.81
-0.98 (-2.19%)
At close: Jul 7, 2025, 4:00 PM
44.32
+0.51 (1.16%)
After-hours: Jul 7, 2025, 7:03 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $3.07 billion as of July 7, 2025. Its market cap has increased by 60.57% in one year.
Market Cap
3.07B
Enterprise Value
2.38B
1-Year Change
60.57%
Ranking
Category
Stock Price
$43.81
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $3.07B, an increase of 268.36%. That is a compound annual growth rate of 30.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 3.07B | 17.98% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |